强直性脊柱炎与肺炎住院后死亡率:一项基于人群的队列研究
该研究基于丹麦1997–2017年全国队列,比较强直性脊柱炎(AS)与非AS肺炎住院患者的90天死亡率、再入院率及肺部并发症。结果显示AS患者90天死亡率未增加(调整HR 0.95,95%CI 0.79–1.16),近期再入院和肺部并发症风险亦未升高。
要点
- AS合并肺炎住院患者90天死亡率未显著高于非AS患者。
- AS患者90天再入院风险调整后无显著差异(HR 1.12)。
- 肺部并发症相对风险随研究时期下降,近期无显著增加。
核心结论
- 强直性脊柱炎与肺炎住院后死亡率增加无关。
- 近期研究年份中AS患者再入院或肺部并发症风险未见增加。
研究设计与样本
- 采用Cox回归分析计算粗率和调整后风险比,调整因素包括性别、年龄和合并症水平。
主要发现
- AS患者90天死亡率为12.5%,非AS患者为15.5%;粗HR 0.79(95%CI 0.66–0.96),调整HR 0.95(95%CI 0.79–1.16)。
- AS患者出院后90天再入院率为27.3%,非AS患者为25.4%;调整再入院HR 1.12(95%CI 0.98–1.27)。
- 肺部并发症相对风险在1997–2006年调整HR为1.63(95%CI 0.82–3.27),2007–2017年降至0.62(95%CI 0.31–1.23)。
临床怎么用
- AS患者因肺炎住院时,无需因AS本身而预期更高的死亡风险。
- 近期AS肺炎住院患者的再入院和肺部并发症风险与非AS患者相当。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Little is known about the prognosis of infections in patients with ankylosing spondylitis (AS) compared with patients without AS. The purpose of this study was to examine whether AS is associated with poorer outcomes in patients who are hospitalised with pneumonia. METHODS: In a population-based cohort study including patients with hospitalised pneumonia with and without AS, we compared 90-day rates of mortality, all-cause readmission (90 days post-discharge) and pulmonary complications including pulmonary embolism, empyema and pulmonary abscess. We used Cox regression analyses to compute crude and adjusted HRs while adjusting for sex, age and level of comorbidity. RESULTS: A total of 387 796 patients (median age 71 years) were hospitalised for pneumonia in Denmark between 1997 and 2017. Among these, 842 (0.2%) had AS (median age 65 years). The 90-day mortality was 12.5% in patients with AS and 15.5% in patients with non-AS pneumonia, with crude and adjusted 90-day HRs of 0.79 (95% CI 0.66 to 0.96) and 0.95 (95% CI 0.79 to 1.16), respectively. The 90-day post-discharge readmission rate was 27.3% in patients with AS and 25.4% in patients without AS, with a corresponding adjusted readmission HR of 1.12 (95% CI 0.98 to 1.27). Relative risk of pulmonary complications among patients with AS compared with patients without AS decreased over the study period, with adjusted HRs of 1.63 (95% CI 0.82 to 3.27) in 1997-2006 falling to 0.62 (95% CI 0.31 to 1.23) in 2007-2017. CONCLUSIONS: AS is not associated with increased mortality following hospitalisation for pneumonia. Furthermore, no increased risk of readmission or pulmonary complications in patients with AS was detected in recent study years.
引用
- Holland-Fischer M, Thomsen RW, Tarp U, et al. Ankylosing spondylitis and mortality following hospitalised pneumonia: a population-based cohort study. RMD Open. 2020. PMID: 32396522. doi:10.1136/rmdopen-2019-001140
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。